S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10

Allscripts Healthcare Solutions (MDRX) Stock Forecast, Price & News

-0.08 (-0.47%)
(As of 05/27/2022 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
1.30 million shs
Average Volume
1.80 million shs
Market Capitalization
$1.96 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive MDRX News and Ratings via Email

Sign-up to receive the latest news and ratings for Allscripts Healthcare Solutions and its competitors with MarketBeat's FREE daily newsletter.

Allscripts Healthcare Solutions logo

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc., together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated clinical and financial management solutions, which primarily include EHR-related software; and related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Veradigm segment offers payer and life sciences solutions, which are primarily targeted at payers, life sciences companies, and other healthcare stakeholders; and software applications for patient engagement and EHR software to single-specialty, and small and mid-sized physician practices, including related clinical, financial, administrative, and operational solutions. Its solutions enable clients to transition, analyze, and coordinate care, and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments and militaries, health systems, health plans, life-sciences companies, retail clinics, surgery centers, retail pharmacies, pharmacy benefit managers, insurance companies, employer wellness clinics, consumers, lab companies, urgent care facilities, and venture capital firms, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.


Analyst Ratings for Allscripts Healthcare
Allscripts Healthcare Solutions Inc. Q1 Income Climbs
See More Headlines

Industry, Sector and Symbol

Computer integrated systems design
Health Care Technology
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$1.50 billion
Cash Flow
$2.78 per share
Book Value
$11.66 per share


Net Income
$134.44 million
Pretax Margin




Free Float
Market Cap
$1.96 billion

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Social Links


Overall MarketRank

1.68 out of 5 stars

Medical Sector

930th out of 1,424 stocks

Computer Integrated Systems Design Industry

33rd out of 50 stocks

Analyst Opinion: 3.3Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -

Allscripts Healthcare Solutions (NASDAQ:MDRX) Frequently Asked Questions

Is Allscripts Healthcare Solutions a buy right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Allscripts Healthcare Solutions in the last twelve months. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Allscripts Healthcare Solutions stock.
View analyst ratings for Allscripts Healthcare Solutions
or view top-rated stocks.

When is Allscripts Healthcare Solutions' next earnings date?

Allscripts Healthcare Solutions is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Allscripts Healthcare Solutions

How were Allscripts Healthcare Solutions' earnings last quarter?

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) released its earnings results on Thursday, May, 5th. The software maker reported $0.09 EPS for the quarter, missing analysts' consensus estimates of $0.13 by $0.04. The software maker had revenue of $142.70 million for the quarter, compared to analysts' expectations of $139.67 million. Allscripts Healthcare Solutions had a trailing twelve-month return on equity of 10.97% and a net margin of 11.60%. The firm's quarterly revenue was up 6.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.13 earnings per share.
View Allscripts Healthcare Solutions' earnings history

How will Allscripts Healthcare Solutions' stock buyback program work?

Allscripts Healthcare Solutions announced that its board has approved a share buyback plan on Wednesday, May 26th 2021, which permits the company to repurchase $350,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to buy up to 14% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company's management believes its stock is undervalued.

What guidance has Allscripts Healthcare Solutions issued on next quarter's earnings?

Allscripts Healthcare Solutions updated its FY 2022 earnings guidance on Monday, May, 23rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.52 billion-$1.53 billion, compared to the consensus revenue estimate of $1.53 billion.

What price target have analysts set for MDRX?

5 brokers have issued 1 year price targets for Allscripts Healthcare Solutions' shares. Their forecasts range from $19.00 to $26.00. On average, they expect Allscripts Healthcare Solutions' stock price to reach $22.00 in the next year. This suggests a possible upside of 30.2% from the stock's current price.
View analysts' price targets for Allscripts Healthcare Solutions
or view top-rated stocks among Wall Street analysts.

Who are Allscripts Healthcare Solutions' key executives?
Allscripts Healthcare Solutions' management team includes the following people:
  • Mr. Paul M. Black, CEO & Director (Age 64, Pay $2.77M) (LinkedIn Profile)
  • Mr. Richard J. Poulton, Pres & CFO (Age 57, Pay $1.92M) (LinkedIn Profile)
  • Ms. Tejal Vakharia, Sr. VP and Gen. Counsel of Marketing & Gov. Affairs (Age 49, Pay $630.22k)
  • Mr. Dave Dornstreich, VP Strategic Initiatives & Data Partnerships of Payer and Life Sciences Division
  • Mr. Joseph R. Rostock, Sr. VP of Devel. & CTO (Age 59)
  • Jenny Gelinas, VP of Investor Relations
  • Mr. Richard Elmore, Sr. VP of Corp. Devel. & Strategy
  • Ms. Leah Jones, Sr. VP of Sales Operations
  • Ms. Rebecca Whaley, VP of Marketing
  • Ms. Lisa Hammond, Sr. VP & Chief HR
What is Paul Black's approval rating as Allscripts Healthcare Solutions' CEO?

796 employees have rated Allscripts Healthcare Solutions CEO Paul Black on Glassdoor.com. Paul Black has an approval rating of 65% among Allscripts Healthcare Solutions' employees.

Who are some of Allscripts Healthcare Solutions' key competitors?
What other stocks do shareholders of Allscripts Healthcare Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Allscripts Healthcare Solutions investors own include Advanced Micro Devices (AMD), Netflix (NFLX), Energy Transfer (ET), CVS Health (CVS), Ford Motor (F), Himax Technologies (HIMX), Intel (INTC), OPKO Health (OPK), Tesla (TSLA) and Activision Blizzard (ATVI).

What is Allscripts Healthcare Solutions' stock symbol?

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

Who are Allscripts Healthcare Solutions' major shareholders?

Allscripts Healthcare Solutions' stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (19.91%), Vanguard Group Inc. (11.94%), Dimensional Fund Advisors LP (8.34%), Fisher Asset Management LLC (4.83%), State Street Corp (3.83%) and Fuller & Thaler Asset Management Inc. (3.31%). Company insiders that own Allscripts Healthcare Solutions stock include Elaina Shekhter, Elizabeth Ann Altman, Greg Garrison, Lisa Khorey, Michael Klayko, Paul Black, Richard J Poulton and Thomas Langan.
View institutional ownership trends for Allscripts Healthcare Solutions

Which institutional investors are selling Allscripts Healthcare Solutions stock?

MDRX stock was sold by a variety of institutional investors in the last quarter, including Shapiro Capital Management LLC, Wellington Management Group LLP, JPMorgan Chase & Co., BlackRock Inc., Invesco Ltd., Goldman Sachs Group Inc., Fuller & Thaler Asset Management Inc., and Dimensional Fund Advisors LP. Company insiders that have sold Allscripts Healthcare Solutions company stock in the last year include Elaina Shekhter, Elizabeth Ann Altman, Greg Garrison, Lisa Khorey, Michael Klayko, Paul Black, Richard J Poulton, and Thomas Langan.
View insider buying and selling activity for Allscripts Healthcare Solutions
or view top insider-selling stocks.

Which institutional investors are buying Allscripts Healthcare Solutions stock?

MDRX stock was acquired by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Alyeska Investment Group L.P., Renaissance Technologies LLC, Hillsdale Investment Management Inc., Mckinley Capital Management LLC Delaware, WINTON GROUP Ltd, Burney Co., and EAM Investors LLC.
View insider buying and selling activity for Allscripts Healthcare Solutions
or or view top insider-buying stocks.

How do I buy shares of Allscripts Healthcare Solutions?

Shares of MDRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Allscripts Healthcare Solutions' stock price today?

One share of MDRX stock can currently be purchased for approximately $16.90.

How much money does Allscripts Healthcare Solutions make?

Allscripts Healthcare Solutions has a market capitalization of $1.96 billion and generates $1.50 billion in revenue each year. The software maker earns $134.44 million in net income (profit) each year or $1.12 on an earnings per share basis.

How many employees does Allscripts Healthcare Solutions have?

Allscripts Healthcare Solutions employs 8,000 workers across the globe.

Does Allscripts Healthcare Solutions have any subsidiaries?

The following companies are subsidiares of Allscripts Healthcare Solutions: HealthGrid, Practice Fusion, and ZappRx.

When was Allscripts Healthcare Solutions founded?

Allscripts Healthcare Solutions was founded in 1986.

What is Allscripts Healthcare Solutions' official website?

The official website for Allscripts Healthcare Solutions is www.allscripts.com.

How can I contact Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. The software maker can be reached via phone at (800) 334-8534, via email at [email protected], or via fax at 313-322-9600.

This page was last updated on 5/28/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.